aminocaproic acid has been researched along with Blue Toe Syndrome in 1 studies
Aminocaproic Acid: An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.
6-aminohexanoic acid : An epsilon-amino acid comprising hexanoic acid carrying an amino substituent at position C-6. Used to control postoperative bleeding, and to treat overdose effects of the thrombolytic agents streptokinase and tissue plasminogen activator.
Blue Toe Syndrome: A condition that is caused by recurring atheroembolism in the lower extremities. It is characterized by cyanotic discoloration of the toes, usually the first, fourth, and fifth toes. Discoloration may extend to the lateral aspect of the foot. Despite the gangrene-like appearance, blue toes may respond to conservative therapy without amputation.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jy, W | 1 |
| Gagliano-DeCesare, T | 1 |
| Kett, DH | 1 |
| Horstman, LL | 1 |
| Jimenez, JJ | 1 |
| Ruiz-Dayao, Z | 1 |
| Santos, ES | 1 |
| Ahn, YS | 1 |
1 other study available for aminocaproic acid and Blue Toe Syndrome
| Article | Year |
|---|---|
Life-threatening bleeding from refractory acquired FVIII inhibitor successfully treated with rituximab.
Topics: Aged; Aged, 80 and over; Aminocaproic Acid; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-D | 2003 |